First Trust NYSE Arca Biotechnology Index Fund
122 hedge funds and large institutions have $1.98B invested in First Trust NYSE Arca Biotechnology Index Fund in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 59 increasing their positions, 26 reducing their positions, and 15 closing their positions.
127% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 26
80% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 15
50% more capital invested
Capital invested by funds: $1.32B → $1.98B (+$660M)
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
38% more call options, than puts
Call options by funds: $3.51M | Put options by funds: $2.54M
9% more funds holding
Funds holding: 112 → 122 (+10)
0.57% more ownership
Funds ownership: 60.36% → 60.93% (+0.57%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$308M |
| 2 |
Morgan Stanley
New York
|
+$26.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$19.5M |
| 4 |
Goldman Sachs
New York
|
+$17M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.48M |
| 2 |
FMP
Financial Management Professionals
Austin,
Texas
|
-$3.54M |
| 3 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
-$3.12M |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$2.89M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.3M |
FBT Hedge Fund Activity: Q1 2015 in Review
122 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2015, worth a combined $1.98B — up 50% from $1.32B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new FBT positions and 15 closed out — a net gain of 12 holders — while 59 added to existing stakes and 26 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $308M. The largest seller was Citadel Advisors, exiting entirely with an estimated $4.48M sold.
- 122 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2015, up from 112 in Q4 2014.
- Funds reported $1.98B of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2015, up 50% quarter-over-quarter.
- 27 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2015 and 15 closed out, a net change of +12 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2015 was First Trust Advisors, an estimated $308M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2015 was Citadel Advisors, an estimated $4.48M sold.
Based on aggregated 13F filings for Q1 2015.